Clinical Trial Update: Safety, Tolerability, and Preliminary Efficacy of Hepatocyte-like Cell Injection for the Prevention and Treatment of Small-for-Size Syndrome [EARLY_Phase 1]

View source ↗

Summary

Ongoing Phase 1 clinical trial evaluating safety, tolerability, and preliminary efficacy of hepatocyte-like cell injections to prevent and treat small-for-size …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small-for-size Syndrome

Drugs mentioned

• Hepatocyte-like cell injection

Snippet

Sponsor: Zhi-Jun Zhu | Conditions: Small-for-size Syndrome | EARLY_Phase 1 | Status: ENROLLING_BY_INVITATION